BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8631562)

  • 1. Invasive adenocarcinoma of the cervix following Lletz for adenocarcinoma in situ.
    Townsend DE
    Gynecol Oncol; 1996 Feb; 60(2):332. PubMed ID: 8631562
    [No Abstract]   [Full Text] [Related]  

  • 2. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ.
    Kennedy AW; elTabbakh GH; Biscotti CV; Wirth S
    Gynecol Oncol; 1995 Aug; 58(2):274-7. PubMed ID: 7622120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma in situ of the uterine cervix: management and outcome.
    Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
    Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma in situ of the cervix--the margins must be clear.
    Hopkins MP
    Gynecol Oncol; 2000 Oct; 79(1):4-5. PubMed ID: 11006021
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can cervical adenocarcinoma in situ be safely managed by conization alone?
    Muntz HG
    Gynecol Oncol; 1996 Jun; 61(3):301-3. PubMed ID: 8641605
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].
    Dedecker F; Graesslin O; Bonneau S; Quéreux C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):616-22. PubMed ID: 18539502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive adenocarcinoma of the vagina following surgery for adenocarcinoma in situ of the cervix--recurrence or implantation?
    Narayansingh GV; Cumming GP; Dighe S; Parkin DE; Millar I
    Int J Gynecol Cancer; 2001; 11(6):493-5. PubMed ID: 11906556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix.
    Shipman SD; Bristow RE
    Curr Opin Oncol; 2001 Sep; 13(5):394-8. PubMed ID: 11555719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
    Schorge JO; Lea JS; Ashfaq R
    J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suitable treatment for adenocarcinoma in situ of uterine cervix: a report of four cases.
    Liu YC; Chen RJ; Chang DY; Huang SC; Chow SN
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Oct; 58(4):294-8. PubMed ID: 8994337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
    Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of coexisting squamous cell lesions on prognosis in patients with cervical adenocarcinoma in situ.
    Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
    Eur J Obstet Gynecol Reprod Biol; 2015 Jul; 190():26-30. PubMed ID: 25956340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ.
    Miller B; Dunn J; Dalrymple J; Krivak TC
    Gynecol Oncol; 2005 Nov; 99(2):489-92. PubMed ID: 16054200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence of carcinoma in situ of the vaginal portion of the cervix uteri following radical treatment].
    Verschoof KJ; de la Fuente AA
    Ned Tijdschr Geneeskd; 1982 Nov; 126(46):2093-6. PubMed ID: 7177214
    [No Abstract]   [Full Text] [Related]  

  • 20. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.
    Cohn DE; Morrison CD; Zanagnolo VL; Goist MM; Copeland LJ
    Gynecol Oncol; 2005 Jul; 98(1):158-60. PubMed ID: 15913738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.